Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.
May 23, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Latest patent broadens protection around OCEA’s platform of first-in-class anti-CHi3L1 therapeutic immunotherapy candidates, based on the breakthrough discovery by scientific co-founder, Dr. Jack A....
Blue Eye Soft announces patent award for Artificial Intelligence Technology
February 07, 2022 14:45 ET
|
Blue Eye Soft
Greenville, SC, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Blue Eye Soft is excited to announce that the U.S. Patent Office has officially awarded a utility patent for the company’s artificial intelligence...
AZTEC AWARDS Named to INC. 5000
August 23, 2011 15:09 ET
|
AZTEC AWARDS
San Diego, CA, Aug. 23, 2011 (GLOBE NEWSWIRE) -- AZTEC AWARDS, A San Diego-based provider of corporate awards & IP recognition products, today announced that it has been named to Inc. magazine’s...